Aims The intermittent administration of chemotherapy is a means of preserving ... to verify whether the intermittent administration of docetaxel (DOC) improves the patients' QL.

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically ...

When the drug binds to CD47, it helps destroy the cancer cells directly. In the study, magrolimab was combined with docetaxel, a type of chemotherapy. The study included 31 patients with metastatic ...

Abiraterone acetate plus prednisone also improves rPFS and enzalutamide improves rPFS and OS in chemotherapy-naive CRPC patients. Docetaxel plus prednisone as a first-line chemotherapy ...

Advanced triple-negative breast cancer is usually treated with chemotherapy – but response rates remain low. Researchers designed the trial to compare the effectiveness of docetaxel with carboplatin – ...

The US regulator has approved Nubeqa (darolutamide) in combination with docetaxel chemotherapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC), adding to its earlier ...

You may also hear of these being called chemotherapy medicines ... However, your doctor has now decided to treat you with docetaxel.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Patients randomized to receive Optune Lua and docetaxel (n=75 ... Since 1991, radiation with a combination of platinum-based chemotherapy drugs has been the first-line standard of care for ...